Demonpore is a technology company.
Our mission is utility-scale molecular sensing: the infrastructure that will answer 'what molecules are in this?' for everyone everywhere, about any part of molecular reality.
Demonpore has raised $120K across 1 funding round.
Demonpore has raised $120K in total across 1 funding round.
Demonpore has raised $120K in total across 1 funding round.
Demonpore's investors include 305 Ventures, Alpine Ventures, CapitalG, Concept Ventures, Goodwater Capital, Maven Capital Partners, Playfair Capital, David Haywood Smith, David Mytton, Jeremy Yap, Klaus Nyengaard, Matteo Gamba.
Demonpore (now operating as Molecular Reality Corp) is a biotechnology startup pioneering Molecular Reality (MR), a platform blending gaming, education, and molecular research through nanopore-based hardware. Their flagship product, Demonpore 64, is the world's first molecular gaming console that enables users to interact with real cells and molecules in real-time, powered by solid-state nanopores for utility-scale molecular sensing.[1][2][6] It serves gamers, educators, students, and researchers by solving the problem of inaccessible hands-on molecular biology, making it as intuitive as playing a video game while doubling as a research station.[1][2]
Backed by Y Combinator (S18 batch) and Methuselah, the company has raised funds via Wefunder and focuses on consumer biotech and internet tools from its Oakland, California base, with a small team of about 2 employees.[3][4] This positions Demonpore at the intersection of entertainment and science, driving growth through crowdfunding and institutional support amid rising demand for interactive biotech tools.[1][3]
Demonpore emerged from Y Combinator's S18 batch as Demonpore Inc, a trailblazing venture in Molecular Reality (MR)—touted as a paradigm shift comparable to VR or AR.[3] The idea stemmed from founders aiming to democratize molecular interaction, leading to the development of Demonpore 64, a hardware platform using nanopores to let users "play" with actual biological entities like cells and molecules.[1][2] Early traction came via crowdfunding on Wefunder, highlighting its dual role as a gaming console and molecular lab, with major backers including Y Combinator and Methuselah providing credibility and resources.[1][3]
The company has evolved into Molecular Reality Corp, shifting emphasis toward building an "electrical grid for biology"—scalable, real-time molecular sensors as ubiquitous as WiFi—while retaining its Oakland roots in biotech, consumer tech, and internet services.[4][6] Pivotal moments include product launches covered in gaming and crowdfunding circles, marking its transition from niche innovator to broader biotech utility provider.[2][3]
Demonpore stands out in biotech and edutainment through these key strengths:
Demonpore rides the wave of converging biotech, gaming, and edtech trends, where interactive simulations meet real-world biology amid advances in nanopore sequencing and synthetic biology. Timing aligns with post-2020 surges in remote learning and personalized medicine, fueled by market forces like falling sensor costs and demand for hands-on STEM tools beyond screens.[1][2][6] It influences the ecosystem by pioneering consumer-accessible molecular tech, potentially accelerating discoveries in drug development and biohacking while inspiring similar hybrid devices—much like how VR democratized immersion.[3]
Demonpore is poised to expand its Molecular Reality platform beyond gaming into widespread biotech utilities, leveraging nanopore scalability for applications in health monitoring, environmental sensing, and education. Trends like AI-driven biology and edge computing will amplify its grid-like sensor network, potentially growing influence through partnerships with pharma giants or edtech platforms. As biotech gaming hybrids mature, Demonpore could redefine molecular access, evolving from YC-backed pioneer to infrastructure leader—echoing its original promise of making cells as playable as pixels.[1][3][6]
Demonpore has raised $120K across 1 funding round. Most recently, it raised $120K Seed in August 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2018 | $120K Seed | 305 Ventures, Alpine Ventures, CapitalG, Concept Ventures, Goodwater Capital, Maven Capital Partners, Playfair Capital, David Haywood Smith, David Mytton, Jeremy Yap, Klaus Nyengaard, Matteo Gamba, Michael Moritz, Siddharth Singhal |